Xueren Feng

Huzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Osimertinib for an Advanced NSCLC Patient with Two Common EGFR Mutations and a Concomitant MET Exon 14 Skipping Mutation: A Case Report.

Osimertinib for an Advanced NSCLC Patient with Two Common EGFR Mutations and a Concomitant MET Exon 14 Skipping Mutation: A Case Report.

Journal: Cancer management and research

Published: March 12, 2023

Case Report: Heterogeneity of Resistance Mechanisms in Different Lesions Co-Mediate Acquired Resistance to First-Line Icotinib in EGFR Mutant Non-Small Cell Lung Cancer.

Case Report: Heterogeneity of Resistance Mechanisms in Different Lesions Co-Mediate Acquired Resistance to First-Line Icotinib in EGFR Mutant Non-Small Cell Lung Cancer.

Journal: Frontiers in medicine

Published: March 28, 2022

Predictive Equations for Adult Pulmonary Function in Zhejiang Province, China.

Predictive Equations for Adult Pulmonary Function in Zhejiang Province, China.

Journal: Journal of tropical medicine

Published: September 05, 2021

Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports.

Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports.

Journal: OncoTargets and therapy

Published: April 08, 2020

circRNAs and Exosomes: A Mysterious Frontier for Human Cancer.

circRNAs and Exosomes: A Mysterious Frontier for Human Cancer.

Journal: Molecular therapy. Nucleic acids

Published: August 13, 2019

Clinicopathological and prognostic significance of NCALD protein expression in lung adenocarcinoma.

Clinicopathological and prognostic significance of NCALD protein expression in lung adenocarcinoma.

Journal: Translational cancer research

Published: November 30, 2018

Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.

Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.

Journal: EBioMedicine

Published: June 13, 2018

RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC.

RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC.

Journal: PloS one

Published: May 24, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026